<DOC>
	<DOCNO>NCT02479906</DOCNO>
	<brief_summary>The purpose present study evaluate safety efficacy Brainsway Deep TMS ( DTMS ) treatment PTSD .</brief_summary>
	<brief_title>A Safety &amp; Efficacy Study With Deep Transcranial Magnetic Stimulation Treatment Post-Traumatic Stress Disorder ( PTSD )</brief_title>
	<detailed_description>Deep TMS conjunction brief trauma exposure compare sham treatment conjunction brief trauma exposure , multicenter , randomize , control study treatment PTSD . Study duration 9 week , consist 4 week treatment 5 week 9 week follow-up visit . Subjects randomize real sham treatment stratify site . The design meant demonstrate device show superiority compare sham treatment 5 week follow-up visit 9 week follow-up visit , 1 month post-treatment .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<criteria>Outpatients Men woman 2268 year age Subjects currently diagnose PTSD accord DSM5 , use CAPS5 ( pastmonth version ) , follow criterion meet : Criterion B : least 1/5 intrusion symptom ; Criteria C : least 1/2 avoidance symptom ; Criteria D : least 2/7 cognition &amp; mood symptom ; Criteria E : least 2/6 arousal &amp; reactivity symptom ; Criterion F : duration meet ; Criteria G : distress meet . Subjects least moderate PTSD CAPS5 score ≥ 25 Screening Baseline visit . Subjects HDRS21 score ≤ 26 Screening Baseline visit . Subjects negative mitigate answer safety screen questionnaire transcranial magnetic stimulation . Negative pregnancy test childbearing age woman . Subject capable willing provide inform consent . Subject able adhere treatment schedule . Subject diagnose accord SCID I suffer major Axis I disorder , Psychotic Disorder , Bipolar affective disorder , OCD ( MDD contraindicate HDRS21≤26 ) . Subjects diagnose accord SCID II suffer Severe Personality Disorder . Subjects significant suicidal risk assess investigator use Beck Suicide Ideation scale , psychiatric interview history attempt suicide past year . Subject history epilepsy seizure ( EXCEPT therapeutically induce ECT ) . Subject history significant head trauma loss consciousness longer 5 minute . Subject history cranial surgery . Subject metallic particle eye head ( exclusive mouth ) , implanted cardiac pacemaker intracardiac line , implanted neurostimulators , intracranial implant ( e.g. , aneurysm clip , shunt , stimulators , cochlear implant , electrode ) implant medical pump . Subject severe frequent headache . Subject history significant hearing loss . Subjects significant neurological disorder insult include , limited : Any condition likely associate increase intracranial pressure Space occupy brain lesion History cerebrovascular accident Transient ischemic attack within two year Cerebral aneurysm MMSE ≤ 24 Parkinson 's disease Huntington 's chorea Multiple sclerosis Subject history substance abuse include alcoholism within past 6 month ( except nicotine caffeine ) . Inadequate communication patient . Subject custodial care . Subject currently participate another clinical study enrol another clinical study within 30 day prior study . Subject unstable physical disease unstable cardiac disease . Subject currently Benzodiazepine dose high 3 mg Lorazepam equivalent . Subject previous treatment TMS . Women breastfeed . Women childbearing potential use medically accept form contraception sexually active .</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>68 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Post-Traumatic Stress Disorder</keyword>
	<keyword>PTSD</keyword>
	<keyword>dTMS</keyword>
</DOC>